Sohanya Cheng - Jun 13, 2022 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Chief Commercial Officer
Signature
/s/Nancy Smith as Attorney-in-Fact for Sohanya Cheng
Stock symbol
KPTI
Transactions as of
Jun 13, 2022
Transactions value $
-$8,075
Form type
4
Date filed
6/14/2022, 07:25 PM
Previous filing
Mar 2, 2022
Next filing
Sep 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale -$353 -66 -0.07% $5.35 91.4K Jun 13, 2022 Direct F1
transaction KPTI Common Stock Sale -$7.72K -1.49K -1.62% $5.20 89.9K Jun 13, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.